Literature DB >> 32979881

The case for simplifying and using absolute targets for viral hepatitis elimination goals.

.   

Abstract

The 69th World Health Assembly endorsed the Global Health Sector Strategy for Viral Hepatitis, embracing a goal to eliminate hepatitis infection as a public health threat by 2030. This was followed by the World Health Organization's (WHO) global targets for the care and management of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. These announcements and targets were important in raising awareness and calling for action; however, tracking countries' progress towards these elimination goals has provided insights to the limitations of these targets. The existing targets compare a country's progress relative to its 2015 values, penalizing countries who started their programmes prior to 2015, countries with a young population, or countries with a low prevalence. We recommend that (1) WHO simplify the hepatitis elimination targets, (2) change to absolute targets and (3) allow countries to achieve these disease targets with their own service coverage initiatives that will have the maximum impact. The recommended targets are as follows: reduce HCV new chronic cases to ≤5 per 100 000, reduce HBV prevalence among 1-year-olds to ≤0.1%, reduce HBV and HCV mortality to ≤5 per 100 000, and demonstrate HBV and HCV year-to-year decrease in new HCV- and HBV-related HCC cases. The objective of our recommendations is not to lower expectations or diminish the hepatitis elimination standards, but to provide clearer targets that recognize the past and current elimination efforts by countries, help measure progress towards true elimination, and motivate other countries to follow suit.
© 2020 John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 32979881     DOI: 10.1111/jvh.13412

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  8 in total

1.  Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: A simulation study.

Authors:  Junko Tanaka; Akemi Kurisu; Masatsugu Ohara; Serge Ouoba; Masayuki Ohisa; Aya Sugiyama; Michelle L Wang; Lindsey Hiebert; Tatsuya Kanto; Tomoyuki Akita
Journal:  Lancet Reg Health West Pac       Date:  2022-03-16

Review 2.  Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis.

Authors:  Mohammadreza Pourkarim; Shahnaz Nayebzadeh; Seyed Moayed Alavian; Seyyed Hassan Hataminasab
Journal:  Pathogens       Date:  2022-05-29

Review 3.  Challenges in Formulation and Implementation of Hepatitis B Elimination Programs.

Authors:  Zaigham Abbas; Minaam Abbas
Journal:  Cureus       Date:  2021-04-24

4.  Pregnant women's hepatitis B vaccination coverage in Nigeria: a national pilot cross-sectional study.

Authors:  George Uchenna Eleje; Godwin Otuodichinma Akaba; Ikechukwu Innocent Mbachu; Ayyuba Rabiu; Olabisi Morebise Loto; Hadiza Abdullahi Usman; Preye Owen Fiebai; Rebecca Chinyelu Chukwuanukwu; Ngozi Nneka Joe-Ikechebelu; Chike Henry Nwankwo; Stephen Okoroafor Kalu; Chinyere Ukamaka Onubogu; Chukwuanugo Nkemakonam Ogbuagu; Shirley Nneka Chukwurah; Chinwe Elizabeth Uzochukwu; Samuel Oluwagbenga Inuyomi; Bukola Abimbola Adesoji; Uchenna Chukwunonso Ogwaluonye; Sussan Ifeyinwa Nweje; Richard Obinwanne Egeonu; Odion Emmanuel Igue; Chiamaka Henrietta Jibuaku; Prince Ogbonnia Aja; Chiamaka Perpetua Chidozie; Hadiza Sani Ibrahim; Fatima Ele Aliyu; Aisha Ismaila Numan; Ogbonna Dennis Okoro; Solace Amechi Omoruyi; Ijeoma Chioma Oppah; Ubong Inyang Anyang; Aishat Ahmed; Osita Samuel Umeononihu; Eric Okechukwu Umeh; Ekene Agatha Emeka; Arinze Anthony Onwuegbuna; Emeka Philip Igbodike; Ifeoma Clara Ajuba; Ibrahim Adamu Yakasai; Oliver Chukwujekwu Ezechi; Joseph Ifeanyichukwu Ikechebelu
Journal:  Ther Adv Vaccines Immunother       Date:  2021-07-29

5.  Elimination of Viral Hepatitis in Low and Middle-Income Countries: Epidemiological Research Gaps.

Authors:  Antoine Jaquet; Guy Muula; Didier K Ekouevi; Gilles Wandeler
Journal:  Curr Epidemiol Rep       Date:  2021-07-31

6.  Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey.

Authors:  Loreta A Kondili; Maria Buti; Mar Riveiro-Barciela; Mojca Maticic; Francesco Negro; Thomas Berg; Antonio Craxì
Journal:  JHEP Rep       Date:  2022-07-27

7.  Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease.

Authors:  Saleh A Alqahtani; Dieter C Broering; Saad A Alghamdi; Khalid I Bzeizi; Noara Alhusseini; Saleh I Alabbad; Ali Albenmousa; Nasreen Alfaris; Faisal Abaalkhail; Waleed K Al-Hamoudi
Journal:  BMC Gastroenterol       Date:  2021-06-01       Impact factor: 3.067

Review 8.  Global Disparities in Hepatitis B Elimination-A Focus on Africa.

Authors:  Mark W Sonderup; C Wendy Spearman
Journal:  Viruses       Date:  2022-01-03       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.